Literature DB >> 30084985

Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1.

Xiao Zhang1, Mingming Wu1, Qing-Yun Chong2,3, Weijie Zhang1, Pengxu Qian4,5, Hong Yan6, Wenchang Qian1, Min Zhang1, Peter E Lobie2,3,7, Tao Zhu1.   

Abstract

The dysregulation of micro RNAs (miRNAs) is a crucial characteristic of human cancers. Herein, we observed frequent amplification of the MIR191/425 locus in breast cancer, which is correlated with poor survival outcome. We demonstrated that the miR-191/425 cluster binds the 3' untranslated region of the DICER1 transcript and posttranscriptionally represses DICER1 expression, thereby impairing global miRNAs biogenesis. Functionally, the forced expression of miR-191 or miR-425 stimulated the proliferation, survival, migration and invasion of breast cancer cells, whereas the inhibition of miR-191 or miR-425 suppressed these oncogenic behaviors of breast cancer cells, in a manner dependent on miR-191/425-mediated downregulation of DICER1. Furthermore, the miR-191/425 cluster promoted breast tumor growth, invasion and metastasis in vivo. The let-7 family of miRNAs was downregulated upon forced expression of miR-191 or miR-425, with a corresponding increase in the levels of let-7 target, high-mobility group AT-hook 2 (HMGA2). The forced expression of let-7 partially abrogated the miR-191/425-mediated oncogenic effects in breast cancer cells, suggestive of let-7 as a downstream effector of the miR-191/425-DICER1 axis. Collectively, we proposed that the inhibition of global miRNA processing, through miR-191/425-mediated downregulation of DICER1, promotes breast cancer progression.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30084985     DOI: 10.1093/carcin/bgy102

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  19 in total

1.  ADRB2 suppresses IL-13-induced allergic rhinitis inflammatory cytokine regulated by miR-15a-5p.

Authors:  Li Wang; Qiaoying Lv; Xicheng Song; Kun Jiang; Junhong Zhang
Journal:  Hum Cell       Date:  2019-05-18       Impact factor: 4.174

Review 2.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

3.  hsa-miR-191-5p inhibits replication of human immunodeficiency virus type 1 by downregulating the expression of NUP50.

Authors:  Yanghao Zheng; Zongxing Yang; Changzhong Jin; Chaoyu Chen; Nanping Wu
Journal:  Arch Virol       Date:  2021-01-08       Impact factor: 2.574

4.  Human bone marrow mesenchymal stem cell-derived exosomes containing microRNA-425 promote migration, invasion and lung metastasis by down-regulating CPEB1.

Authors:  Guoqiang Wang; Xiuli Ji; Pan Li; Wei Wang
Journal:  Regen Ther       Date:  2022-04-25       Impact factor: 3.651

5.  Hsa-miR-425-5p promotes tumor growth and metastasis by activating the CTNND1-mediated β-catenin pathway and EMT in colorectal cancer.

Authors:  Dingsheng Liu; Hong Zhang; Mingming Cui; Chunsheng Chen; Yong Feng
Journal:  Cell Cycle       Date:  2020-06-28       Impact factor: 4.534

6.  Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.

Authors:  Peng-Fei Zhang; Chuan-Yuan Wei; Xiao-Yong Huang; Rui Peng; Xuan Yang; Jia-Cheng Lu; Chi Zhang; Chao Gao; Jia-Bin Cai; Ping-Ting Gao; Dong-Mei Gao; Guo-Ming Shi; Ai-Wu Ke; Jia Fan
Journal:  Mol Cancer       Date:  2019-06-01       Impact factor: 27.401

7.  let-7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1.

Authors:  M-M Qin; X Chai; H-B Huang; G Feng; X-N Li; J Zhang; R Zheng; X-C Liu; C Pu
Journal:  BMC Urol       Date:  2019-06-13       Impact factor: 2.264

8.  Long noncoding RNA LINC00899 suppresses breast cancer progression by inhibiting miR-425.

Authors:  Wenying Zhou; Jiao Gong; Yaqiong Chen; Jiahao Chen; Qi Zhuang; Jing Cao; Zhixiong Mei; Bo Hu
Journal:  Aging (Albany NY)       Date:  2019-11-18       Impact factor: 5.682

9.  Analysis of ceRNA networks and identification of potential drug targets for drug-resistant leukemia cell K562/ADR.

Authors:  Zhaoping Liu; Yanyan Wang; Zhenru Xu; Shunling Yuan; Yanglin Ou; Zeyu Luo; Feng Wen; Jing Liu; Ji Zhang
Journal:  PeerJ       Date:  2021-05-25       Impact factor: 2.984

10.  Five-mRNA Signature for the Prognosis of Breast Cancer Based on the ceRNA Network.

Authors:  Wenjie Shi; Daojun Hu; Sen Lin; Rui Zhuo
Journal:  Biomed Res Int       Date:  2020-09-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.